Antiplatelet agents in coronary disease: are they of prophylactic value?
D000787:Angina Pectoris / Q000150:complications; D001241:Aspirin / Q000627:therapeutic use; D002315:Cardiopulmonary Bypass; D002994:Clofibrate / Q000627:therapeutic use; D003327:Coronary Disease / Q000517:prevention & control*; D004176:Dipyridamole / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006350:Heart Valve Prosthesis; D006801:Humans; D009203:Myocardial Infarction / Q000209:etiology / Q000517:prevention & control / Q000601:surgery; D012008:Recurrence; D013442:Sulfinpyrazone / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D004176:Dipyridamole; D002994:Clofibrate; D001241:Aspirin; D013442:Sulfinpyrazone